Obstructive sleep apnea (OSA) is common and is associated with a number of adverse
outcomes, including an increased risk for cardiovascular disease. Typical treatment …

Obstructive sleep apnea (OSA) is a common disorder characterized by obstructive apneas,
hypopneas, and respiratory effort related arousals during sleep. Treatment of OSA is …

Obstructive sleep apnea (OSA) remains a prominent disease state characterized as the
recurrent collapse of the upper airway while sleeping and is estimated to plague 936 million …

Obstructive sleep apnea (OSA) is a disorder characterized by repetitive collapse of the
upper airway during sleep resulting in frequent awakenings, poor sleep quality, and …

Positive airway pressure (PAP) therapy is the gold standard treatment for patients with
obstructive sleep apnea (OSA) and has been shown to positively impact quality of life and …

Obstructive sleep apnea (OSA) is characterized by recurrent obstruction of the pharyngeal
airway during sleep, with resultant hypoxia and sleep fragmentation. It is more common in …

Obstructive sleep apnea (OSA) is a common disorder affecting 14% of men and 5% of
women when defined by the apnea-hypopnea index (AHI) greater than 5 events/h and …

Introduction: Obstructive sleep apnea (OSA) is a highly prevalent condition affecting persons
of all age with an increasing public health burden. It is implicated in cardiovascular disease …

Obstructive sleep apnea (OSA) affects nearly one billion of the global adult population. It is
associated with substantial burden in terms of quality of life, cognitive function, and …

Introduction The recent continuous positive airway pressure (CPAP) crisis has highlighted
the need for alternative obstructive sleep apnea (OSA) therapies. This article serves to …